← Leaderboards
Carol Getker Shores
University Of North Carolina Chapel Hill
$547,677
Attributed
$547,677
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $135K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$547,677 · 3
By mechanism
K22$540,864 · 1
M01$6,813 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Terry A Van Dyke$19,016,013
- Donald H Baucom$4,967,205
- Yanping Zhang$10,224,049
- Yue Xiong$19,134,640
- Wendell G Yarbrough$10,193,706
Others in their field
Top investigators on “Neoplastic Process”
- David Heimbrook · Leidos Biomedical Research, Inc.$112,211,212
- Michael S. Saag · University Of Alabama At Birmingham$32,218,304
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Mary Kay Washington · Vanderbilt University$24,250,359
- David Sidransky · Johns Hopkins University$21,962,468
- Bruce W Stillman · Cold Spring Harbor Laboratory$21,647,002
Research focus
Neoplastic ProcessP53 Gene /ProteinGamma RadiationTechnology /Technique DevelopmentTissue /Cell CultureHead /Neck NeoplasmNeoplasm /Cancer ChemotherapyNeoplasm /Cancer GeneticsHuman Therapy EvaluationGene ExpressionCisplatinSquamous Cell CarcinomaComplementary DnaApoptosisClinical ResearchMicroarray TechnologyOral MucosaHuman SubjectPatient Oriented ResearchPrognosisDna DamageRadiation ResistanceBiopsyUnited States National Institutes Of Health
Grant awards (7)
DEFINING TUMOR ANOREXIA CACHEXIA SYDROME IN HEAD AND NECK CANCER$6,565
M01 · FY2007 · RR · contact PI
DEFINING TUMOR ANOREXIA CACHEXIA SYDROME IN HEAD AND NECK CANCER$248
M01 · FY2006 · RR · contact PI
Microarray Analysis of HNSCC as a Predictor of Treatment$135,000
K22 · FY2005 · DE
Microarray Analysis of HNSCC as a Predictor of Treatment$135,000
K22 · FY2004 · DE
Microarray Analysis of HNSCC as a Predictor of Treatment$864
K22 · FY2004 · DE
Microarray Analysis of HNSCC as a Predictor of Treatment$135,000
K22 · FY2003 · DE
Microarray Analysis of HNSCC as a Predictor of Treatment$135,000
K22 · FY2002 · DE